High Flow Nasal Oxygen Therapy in Pediatric Intensive Care Unit
Journal Title: Bagcilar Medical Bulletin - Year 2021, Vol 6, Issue 1
Abstract
Objective: Acute respiratory failure is the most common reason for hospitalization to pediatric intensive care units. Invasive and non-invasive respiratory support methods are used for the treatment of patients with acute respiratory failure findings. The aim of this study is to evaluate the effectiveness of high flow nasal cannula (HFNC) oxygen therapy in pediatric intensive care. Method: This retrospective observational study was conducted between February 2017 and January 2018 in pediatric intensive care unit of Bahçeşehir Liv Hospital, İstinye University Faculty of Medicine. Patients aged between 1 month and 18 years, who received HFNC oxygen therapy for respiratory support in the pediatric intensive care unit, were included in the study. Results: HFNC therapy was received by 67 patients during one year of the study. 58.2% of the patients were male. The mean age of the patients was 37.2 months (R, 1-192), and their average body weight was 11.8 kg (R, 2.8-50). 65.7% of patients had an underlying disease. The most underlying disease was neurological disease with the rate of 35.8%. 94% of our patients received HFNC therapy due to acute respiratory failure, 3% due to acute heart failure and 3% due to shock. 40.3% of our patients received HFNC therapy due to pneumonia, 16.4% due to bronchopneumonia, 14.9% due to bronchiolitis, and 11.9% due to postextubation. 71.6% of patients receiving HFNC therapy improved their clinical findings without intubation. After HFNC therapy, there was a statistically considerable decrease in the respiratory rate, heart rate and retraction of the patients. HFNC therapy failure rates were statistically significantly higher in patients with underlying disease and especially in those with cardiac disease. Conclusion: As a result, it is known that HFNC therapy has been used effectively in children in recent years, and it provides improvement in vital findings and blood gas parameters. In our study, 71.6% of our patients benefited from HFNC therapy.
Authors and Affiliations
Ayhan Yaman
Keywords
Related Articles
- EP ID EP693322
- DOI 10.4274/BMB.galenos.2020.10.070
- Views 111
- Downloads 0
Evaluation of Childhood Posterior Fossa Malignant Tumors: A Single-center Study
Objective: The aim of this study is to determine the clinical and radiological findings, early surgical results, and complication rates of children who were admitted to the neurosurgery clinic due to the posterior fossa...
Cepstral Peak Point Analyses of Patients Recovering from Supraglottic Laryngectomy
Objective: The aim of this study is to evaluate smoothed cepstral peak point and laryngostrobosopic results in patients who underwent supraglottic laryngectomy. Method: Ten patients who underwent transcervical supraglot...
Endoscopic Management of Dysphagia in Plummer–Vinson syndrome
Plummer‑Vinson syndrome (PVS), (also called Paterson‑Brown‑Kelly syndrome or sideropenic dysphagia) is an extremely rare syndrome which includes iron-deficiency anemia, dysphagia, and esophageal webs. If left untreated,...
Retrospective Evaluation of the Clinical Findings and Bone Mineral Densitometry Results of Children with Celiac Disease
Objective: Children diagnosed with Celiac disease should be closely followed-up for osteoporosis that may develop. We aimed to evaluate the osteoporosis conditions through bone densitometry in patients with the diagnosis...
Expanding Intensive Care Unit Management for Critically Ill Patients During COVID-19 Pandemic
No Abstract